Medy-Tox Inc. (KOSDAQ:086900)
127,100
+500 (0.39%)
At close: Dec 5, 2025
Medy-Tox Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 892,210 | 831,097 | 1,621,720 | 806,183 | 876,202 | 1,017,738 | Upgrade
|
| Market Cap Growth | -17.72% | -48.75% | 101.16% | -7.99% | -13.91% | -39.32% | Upgrade
|
| Enterprise Value | 912,457 | 890,261 | 1,671,460 | 885,688 | 929,154 | 1,099,207 | Upgrade
|
| Last Close Price | 127100.00 | 123558.21 | 237269.69 | 125467.58 | 133151.58 | 153249.01 | Upgrade
|
| PE Ratio | 37.40 | 52.01 | 184.70 | 22.37 | 9.40 | - | Upgrade
|
| Forward PE | 37.28 | 19.78 | 31.76 | 27.88 | 23.25 | 107.65 | Upgrade
|
| PS Ratio | 3.69 | 3.64 | 7.33 | 4.13 | 4.74 | 7.23 | Upgrade
|
| PB Ratio | 1.91 | 1.74 | 3.42 | 1.86 | 2.17 | 4.16 | Upgrade
|
| P/TBV Ratio | 1.98 | 1.84 | 3.49 | 1.90 | 2.23 | 4.48 | Upgrade
|
| P/FCF Ratio | 16.62 | 29.86 | 276.65 | 49.45 | 357.35 | - | Upgrade
|
| P/OCF Ratio | 14.56 | 22.74 | 119.94 | 30.77 | 43.89 | 36.44 | Upgrade
|
| EV/Sales Ratio | 3.77 | 3.89 | 7.56 | 4.54 | 5.03 | 7.81 | Upgrade
|
| EV/EBITDA Ratio | 18.82 | 22.09 | 51.12 | 14.34 | 18.08 | - | Upgrade
|
| EV/EBIT Ratio | 32.23 | 43.75 | 96.49 | 18.98 | 28.04 | - | Upgrade
|
| EV/FCF Ratio | 17.00 | 31.99 | 285.14 | 54.32 | 378.95 | - | Upgrade
|
| Debt / Equity Ratio | 0.16 | 0.17 | 0.18 | 0.28 | 0.33 | 0.60 | Upgrade
|
| Debt / EBITDA Ratio | 1.83 | 2.02 | 2.53 | 1.96 | 2.59 | - | Upgrade
|
| Debt / FCF Ratio | 1.42 | 2.92 | 14.13 | 7.41 | 54.21 | - | Upgrade
|
| Asset Turnover | 0.40 | 0.37 | 0.37 | 0.33 | 0.35 | 0.32 | Upgrade
|
| Inventory Turnover | 1.84 | 1.45 | 1.56 | 1.61 | 2.25 | 2.00 | Upgrade
|
| Quick Ratio | 1.22 | 1.04 | 0.79 | 0.57 | 1.14 | 0.81 | Upgrade
|
| Current Ratio | 1.79 | 1.67 | 1.31 | 1.00 | 1.49 | 1.18 | Upgrade
|
| Return on Equity (ROE) | 4.38% | 3.38% | 2.13% | 8.74% | 28.77% | -11.84% | Upgrade
|
| Return on Assets (ROA) | 2.23% | 2.07% | 1.79% | 4.97% | 3.96% | -5.21% | Upgrade
|
| Return on Capital (ROIC) | 2.41% | 2.28% | 1.95% | 5.35% | 4.46% | -6.12% | Upgrade
|
| Return on Capital Employed (ROCE) | 4.40% | 4.00% | 3.60% | 10.10% | 7.10% | -10.60% | Upgrade
|
| Earnings Yield | 2.45% | 2.04% | 0.60% | 4.59% | 10.75% | -2.91% | Upgrade
|
| FCF Yield | 6.02% | 3.35% | 0.36% | 2.02% | 0.28% | -1.30% | Upgrade
|
| Dividend Yield | 0.95% | 0.89% | - | - | - | - | Upgrade
|
| Payout Ratio | 36.92% | 49.69% | 86.33% | 21.74% | - | - | Upgrade
|
| Buyback Yield / Dilution | 3.59% | -0.40% | -2.02% | -2.28% | -0.04% | 0.82% | Upgrade
|
| Total Shareholder Return | 4.54% | 0.49% | -2.02% | -2.28% | -0.04% | 0.82% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.